- Home
- BDTX
as 11-24-2025 3:41pm EST
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 220.3M | IPO Year: | 2020 |
| Target Price: | $10.17 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.20 - $4.94 | Next Earning Date: | 11-06-2025 |
| Revenue: | $70,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Black Diamond Therapeutics Inc. News
BDTX Breaking Stock News: Dive into BDTX Ticker-Specific Updates for Smart Investing
Zacks
13 days ago
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Zacks
13 days ago
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run?
Simply Wall St.
18 days ago
3 Promising Penny Stocks With Market Caps Below $600M
Simply Wall St.
18 days ago
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 51% of the company
GlobeNewswire
18 days ago
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Associated Press Finance
19 days ago
Black Diamond: Q3 Earnings Snapshot
GlobeNewswire
19 days ago
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Zacks
25 days ago
Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?
Compare BDTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDTX Black Diamond Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.